Songbo Qiu

1.1k total citations
26 papers, 872 citations indexed

About

Songbo Qiu is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Songbo Qiu has authored 26 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Genetics. Recurrent topics in Songbo Qiu's work include Virus-based gene therapy research (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and CAR-T cell therapy research (4 papers). Songbo Qiu is often cited by papers focused on Virus-based gene therapy research (8 papers), Cancer, Hypoxia, and Metabolism (5 papers) and CAR-T cell therapy research (4 papers). Songbo Qiu collaborates with scholars based in United States, China and Spain. Songbo Qiu's co-authors include Yang Lü, Zhen Fan, Zhihong Ai, Bharat K. R. Chaganty, Cristina Ivan, Anneliese M. M. Gest, George A. Călin, Louis M. Weiner, Xinyuan Liu and Jinfa Gu and has published in prestigious journals such as Hepatology, Biochemical and Biophysical Research Communications and Cancer Letters.

In The Last Decade

Songbo Qiu

25 papers receiving 864 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Songbo Qiu United States 15 483 362 271 144 123 26 872
Ani Arakelian Canada 21 747 1.5× 361 1.0× 332 1.2× 62 0.4× 162 1.3× 30 1.1k
Alejandro Parrales United States 13 698 1.4× 463 1.3× 348 1.3× 45 0.3× 110 0.9× 19 1.1k
Alasdair C. Stamps United Kingdom 12 694 1.4× 291 0.8× 130 0.5× 92 0.6× 63 0.5× 16 1.0k
Nino Keshelava United States 19 914 1.9× 454 1.3× 293 1.1× 66 0.5× 120 1.0× 33 1.4k
Claudia L. Flemming Australia 15 604 1.3× 554 1.5× 219 0.8× 127 0.9× 50 0.4× 22 1.1k
Ashwini A. Katre United States 16 802 1.7× 685 1.9× 350 1.3× 60 0.4× 106 0.9× 31 1.3k
Zili An United States 15 228 0.5× 369 1.0× 112 0.4× 108 0.8× 126 1.0× 24 797
Ricardo López de Cicco United States 15 567 1.2× 363 1.0× 324 1.2× 85 0.6× 61 0.5× 20 1.0k
C H Blood United States 9 481 1.0× 221 0.6× 318 1.2× 183 1.3× 77 0.6× 10 883

Countries citing papers authored by Songbo Qiu

Since Specialization
Citations

This map shows the geographic impact of Songbo Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Songbo Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Songbo Qiu more than expected).

Fields of papers citing papers by Songbo Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Songbo Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Songbo Qiu. The network helps show where Songbo Qiu may publish in the future.

Co-authorship network of co-authors of Songbo Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Songbo Qiu. A scholar is included among the top collaborators of Songbo Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Songbo Qiu. Songbo Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lu, Haiquan, Yang Lü, Yangyiran Xie, et al.. (2019). Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma. JCI Insight. 4(19). 22 indexed citations
3.
Jiang, Zheng, Chunxiang Li, Zhixun Zhao, et al.. (2018). Abnormal Liver Function Induced by Space-Occupying Lesions Is Associated with Unfavorable Oncologic Outcome in Patients with Colorectal Cancer Liver Metastases. BioMed Research International. 2018. 1–7. 8 indexed citations
4.
Chaganty, Bharat K. R., Songbo Qiu, Anneliese M. M. Gest, et al.. (2018). Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion. Cancer Letters. 430. 47–56. 148 indexed citations
5.
6.
Lü, Yang, Chunmei Shi, Songbo Qiu, & Zhen Fan. (2016). Identification and validation of COX-2 as a co-target for overcoming cetuximab resistance in colorectal cancer cells. Oncotarget. 7(40). 64766–64777. 23 indexed citations
7.
Lu, Haiquan, Xinqun Li, Yang Lü, Songbo Qiu, & Zhen Fan. (2016). ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis. Cancer Letters. 381(1). 23–30. 54 indexed citations
8.
Luo, Jingtao, Yun Hong, Yang Lü, et al.. (2016). Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab. Cancer Letters. 384. 39–49. 73 indexed citations
9.
Ruan, Hongmei, Songbo Qiu, Brian C. Beard, & Margaret E. Black. (2016). Creation of zebularine-resistant human cytidine deaminase mutants to enhance the chemoprotection of hematopoietic stem cells. Protein Engineering Design and Selection. 29(12). gzw012–gzw012. 3 indexed citations
10.
Ai, Midan, Songbo Qiu, Yang Lü, & Zhen Fan. (2013). HER2 regulates Brk/PTK6 stability via upregulating calpastatin, an inhibitor of calpain. Cellular Signalling. 25(9). 1754–1761. 14 indexed citations
11.
Ai, Midan, Ke Liang, Yang Lü, Songbo Qiu, & Zhen Fan. (2013). Brk/PTK6 cooperates with HER2 and Src in regulating breast cancer cell survival and epithelial-to-mesenchymal transition. Cancer Biology & Therapy. 14(3). 237–245. 29 indexed citations
12.
Xu, Jing, Yang Lü, Songbo Qiu, Zhi‐Nan Chen, & Zhen Fan. (2013). A novel role of EMMPRIN/CD147 in transformation of quiescent fibroblasts to cancer-associated fibroblasts by breast cancer cells. Cancer Letters. 335(2). 380–386. 31 indexed citations
13.
Liang, Ke, Songbo Qiu, Yang Lü, & Zhen Fan. (2013). Autocrine/paracrine erythropoietin regulates migration and invasion potential and the stemness of human breast cancer cells. Cancer Biology & Therapy. 15(1). 89–98. 13 indexed citations
14.
Wang, Xuefei, et al.. (2011). [Effect of Notch ligand Delta1-RNA interference by lentivirus on proliferation and differentiation of human dental pulp stem cells].. PubMed. 46(12). 730–4. 2 indexed citations
15.
Wang, Xuefei, Fei He, Yinghui Tan, Weidong Tian, & Songbo Qiu. (2011). Inhibition of Delta1 promotes differentiation of odontoblasts and inhibits proliferation of human dental pulp stem cell in vitro. Archives of Oral Biology. 56(9). 837–845. 19 indexed citations
16.
Li, Shiting, et al.. (2011). Amelogenin promotes odontoblast-like MDPC-23 cell differentiation via activation of ERK1/2 and p38 MAPK. Molecular and Cellular Biochemistry. 355(1-2). 91–97. 11 indexed citations
17.
Wang, Yigang, et al.. (2010). An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer. Acta Oncologica. 49(1). 91–99. 20 indexed citations
18.
Zhu, Huabin, Baoli Hu, Weifang Ling, et al.. (2006). Adenovirus E1A reverses the resistance of normal primary human lung fibroblast cells to TRAIL through DR5 upregulation and caspase 8-dependent pathway. Cancer Biology & Therapy. 5(2). 180–188. 8 indexed citations
19.
Qiu, Songbo, Hongmei Ruan, Baoli Hu, et al.. (2004). Combination of Targeting Gene-ViroTherapy with 5-FU Enhances Antitumor Efficacy in Malignant Colorectal Carcinoma. Journal of Interferon & Cytokine Research. 24(4). 219–230. 23 indexed citations
20.
Chu, Liang, Weiguo Zou, Zilai Zhang, et al.. (2004). An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Hepatology. 39(5). 1371–1381. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ani Arakelian Breakdown of academic impact, for papers by Alejandro Parrales Breakdown of academic impact, for papers by Alasdair C. Stamps Breakdown of academic impact, for papers by Nino Keshelava Breakdown of academic impact, for papers by Claudia L. Flemming Breakdown of academic impact, for papers by Ashwini A. Katre Breakdown of academic impact, for papers by Zili An Breakdown of academic impact, for papers by Ricardo López de Cicco Breakdown of academic impact, for papers by C H Blood
Rankless by CCL
2026